Implantable Defibrillators Market Size (2024 - 2029)

The implantable defibrillators market is projected to experience growth due to the increasing prevalence of cardiac arrhythmias and other heart diseases, which drive demand for these devices. The market's expansion is further supported by technological advancements and improved success rates of implantable defibrillators. However, the growth trajectory may be challenged by the stringent regulatory framework governing these devices.

Market Size of Implantable Defibrillators Industry

Implantable Defibrillators Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 4.05 Billion
Market Size (2029) USD 5.52 Billion
CAGR (2024 - 2029) 5.70 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Implantable Defibrillators Market Analysis

The Implantable Defibrillators Market size is estimated at USD 4.05 billion in 2024, and is expected to reach USD 5.52 billion by 2029, growing at a CAGR of 5.70% during the forecast period (2024-2029).

COVID-19 significantly impacted the implantable defibrillator market during the pandemic due to the rise in cardiac arrest among COVID-19 patients. The market declined during the initial pandemic but increased due to the demand for implantable defibrillators in COVID-19 patients. For instance, according to the study published in the Journal of Cardiac Failure in June 2022, implantable cardioverter defibrillators (ICDs) implanted in patients with heart failure provided helpful information on markers of cardiac status such as atrial fibrillation (AF). Thus, it was expected to increase adoption of implantable defibrillators during the COVID-19 pandemic, thereby driving market growth during the late pandemic.

The factors driving the growth of the implantable defibrillators market include the increasing prevalence of cardiac arrhythmias such as ventricular fibrillation, ventricular tachycardia, and other heart diseases such as myocardial infarction or congenital heart diseases.

The rising prevalence of heart diseases such as heart failure is anticipated to drive market growth. For instance, according to the American Heart Association's annual report in 2022, the prevalence rate of heart failure in the United States was around 6 million in 2021, accounting for 1.8% of the total population. Furthermore, according to the Centers for Disease Control and Prevention, in July 2023, the percentage of adults aged 18 and over living with myocardial infarction in the United States in 2022 was 3% of the total population. Such a massive prevalence of myocardial infarction is anticipated to increase the adoption of implantable defibrillators, driving market growth.

In addition, according to the British Heart Foundation, in August 2022, around 7.6 million people in the United Kindom suffered from heart and circulatory diseases 2022. The massive prevalence of cardiovascular disease in developed countries such as the United Kingdom escalates the demand for implantable defibrillators, fueling the target market growth in the studied period.

The rising technological advancements and improved success rates of implantable defibrillators in recent years are anticipated to boost market growth further. For instance, in August 2022, clinical research presented by Medtronic PLC demonstrated the effectiveness of a novel minimally invasive defibrillator implant (Medtronic EV ICD system) intended to stop a sudden cardiac arrest. The extravascular implantable defibrillator system, which includes its primary component under the left armpit, offers backup pacing therapy to reduce vibrations, prevent tachycardia, and help patients avoid defibrillation shock.

Therefore, the increasing prevalence of cardiac arrhythmia and other heart diseases is expected to increase the demand for implantable defibrillators for early access to cardiac arrest. It is further expected to boost the growth of the studied market over the forecast period. However, the stringent regulatory framework for implantable defibrillators is anticipated to impede market growth.

Implantable Defibrillators Industry Segmentation

Implantable Defibrillator/Implantable Cardioverter Defibrillator (ICD) is a battery-powered device placed under the skin that connects the ICD to the patient's heart using thin wires. The ICD keeps track of the heart rate, and if an abnormal heart rhythm is detected, the device will deliver an electric shock to restore a normal heartbeat. The Implantable Defibrillators Market is segmented by type (single chambered, dual chambered, and biventricular), route (transvenous/traditional ICD and Subcutaneous (S-ICD)), end user (hospitals, specialty clinics, and ambulatory surgical centers) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Type
Singel Chambered
Dual Chambered
Biventricular (cardiac resynchronization therapy)
By Route
Transvenous/Traditional ICD
Subcutaneous (S-ICD)
By End User
Hospitals
Speciality Clinics
Ambulatory Surgical Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Implantable Defibrillators Market Size Summary

The implantable defibrillators market is poised for significant growth over the forecast period, driven by the increasing prevalence of cardiac arrhythmias and other heart diseases. The market experienced a decline during the initial phases of the COVID-19 pandemic but saw a resurgence due to the heightened demand for defibrillators among COVID-19 patients experiencing cardiac complications. Technological advancements and improved success rates of implantable defibrillators have further bolstered market growth. The Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) segment, in particular, is expected to grow rapidly due to its advantages over traditional systems, such as reduced risks of complications and enhanced patient safety. Key market players are actively conducting research to validate the efficacy and safety of these devices, which is anticipated to drive further adoption.

North America is expected to maintain a significant share of the implantable defibrillators market, supported by high healthcare expenditures, awareness of the devices' effectiveness, and the presence of major industry players. The United States, in particular, is witnessing increased adoption of defibrillators due to the rising prevalence of cardiovascular diseases and supportive government policies. The market is characterized by a high level of consolidation, with established players like Boston Scientific Corporation, Medtronic PLC, and Abbott leading the charge. Ongoing research and development, along with regulatory approvals, are key factors contributing to the competitive landscape. The market's growth trajectory is further supported by innovative developments, such as the investigational extravascular implantable cardioverter defibrillator system, which promises to enhance treatment options for patients at risk of sudden cardiac arrest.

Explore More

Implantable Defibrillators Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Cardiac Arrhythmia and Other Heart Diseases.

      2. 1.2.2 Technological Advancements in the Field of Implantable Defibrillators

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulatory Framework

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Type

      1. 2.1.1 Singel Chambered

      2. 2.1.2 Dual Chambered

      3. 2.1.3 Biventricular (cardiac resynchronization therapy)

    2. 2.2 By Route

      1. 2.2.1 Transvenous/Traditional ICD

      2. 2.2.2 Subcutaneous (S-ICD)

    3. 2.3 By End User

      1. 2.3.1 Hospitals

      2. 2.3.2 Speciality Clinics

      3. 2.3.3 Ambulatory Surgical Centers

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Implantable Defibrillators Market Size FAQs

The Implantable Defibrillators Market size is expected to reach USD 4.05 billion in 2024 and grow at a CAGR of 5.70% to reach USD 5.52 billion by 2029.

In 2024, the Implantable Defibrillators Market size is expected to reach USD 4.05 billion.

Implantable Defibrillators Market Size & Share Analysis - Growth Trends & Forecast (2024-2029)